129 related articles for article (PubMed ID: 37832824)
1. Comparative effectiveness of cefmetazole versus carbapenems and piperacillin/tazobactam as initial therapy for bacteremic acute cholangitis: A retrospective study.
Aoto K; Inose R; Kosaka T; Shikata K; Muraki Y
J Infect Chemother; 2024 Mar; 30(3):213-218. PubMed ID: 37832824
[TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone versus tazobactam/piperacillin and carbapenems in the treatment of aspiration pneumonia: A propensity score matching analysis.
Asai N; Suematsu H; Ohashi W; Shibata Y; Sakanashi D; Kato H; Shiota A; Watanabe H; Hagihara M; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2021 Oct; 27(10):1465-1470. PubMed ID: 34158237
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of cefmetazole in immunocompetent patients with uncomplicated colonic diverticulitis: A propensity score matching analysis.
Hoshino Y; Ito R; Kikuchi M; Takahashi K; Ishimoto M
J Infect Chemother; 2024 Feb; 30(2):118-122. PubMed ID: 37739180
[TBL] [Abstract][Full Text] [Related]
4. Proposed breakpoint of piperacillin/tazobactam against extended spectrum β-lactamases producing bacteria in bacteremia.
Sugimoto N; Yamagishi Y; Mikamo H
J Infect Chemother; 2017 Jan; 23(1):65-67. PubMed ID: 27693013
[TBL] [Abstract][Full Text] [Related]
5. Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
Ng TM; Khong WX; Harris PN; De PP; Chow A; Tambyah PA; Lye DC
PLoS One; 2016; 11(4):e0153696. PubMed ID: 27104951
[TBL] [Abstract][Full Text] [Related]
6. Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis.
Tsai HY; Chen YH; Tang HJ; Huang CC; Liao CH; Chu FY; Chuang YC; Sheng WH; Ko WC; Hsueh PR
Diagn Microbiol Infect Dis; 2014 Nov; 80(3):222-6. PubMed ID: 25139843
[TBL] [Abstract][Full Text] [Related]
7. [Antigenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
Takemoto M; Matsuo K; Oguro M; Kouchi Y
J Toxicol Sci; 1994 Oct; 19 Suppl 2():249-62. PubMed ID: 7830290
[TBL] [Abstract][Full Text] [Related]
8. [Clinical effects of piperacillin and tazobactam/piperacillin on Haemophilus influenzae lower respiratory tract infection in pediatric patients].
Sudo F; Ishiwada N; Hoshino T; Fukasawa C; Inami Y; Hishiki H; Takeda N; Kurosaki T; Kohno Y
Kansenshogaku Zasshi; 2005 Sep; 79(9):637-43. PubMed ID: 16248372
[TBL] [Abstract][Full Text] [Related]
9. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis.
Hoashi K; Hayama B; Suzuki M; Sakurai A; Takehana K; Enokida T; Takeda K; Ohkushi D; Doi Y; Harada S
Microbiol Spectr; 2022 Aug; 10(4):e0220622. PubMed ID: 35916524
[TBL] [Abstract][Full Text] [Related]
11. Comparing ceftolozane/tazobactam versus piperacillin/tazobactam for the initial empiric therapy of urinary tract infections: A retrospective comparative study.
Nakagawa T; Shigehara K; Shinzawa R; Yaegashi H; Kawaguchi S; Nohara T; Izumi K; Mizokami A
J Infect Chemother; 2024 Jan; 30(1):12-16. PubMed ID: 37660735
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital.
Namikawa H; Yamada K; Fujimoto H; Oinuma KI; Tochino Y; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
Intern Med; 2017; 56(14):1807-1815. PubMed ID: 28717075
[TBL] [Abstract][Full Text] [Related]
13. The use of broad-spectrum antibiotics reduces the incidence of surgical site infection after pancreatoduodenectomy.
Tanaka K; Nakamura T; Imai S; Kushiya H; Miyasaka D; Nakanishi Y; Asano T; Noji T; Tsuchikawa T; Okamura K; Shichinohe T; Hirano S
Surg Today; 2018 Sep; 48(9):825-834. PubMed ID: 29687153
[TBL] [Abstract][Full Text] [Related]
14. Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
Sazanami K; Inose R; Yagi T; Dote S; Horiuchi N; Kobayashi Y; Muraki Y
J Infect Chemother; 2021 Dec; 27(12):1723-1728. PubMed ID: 34446352
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing
Benanti GE; Brown ART; Shigle TL; Tarrand JJ; Bhatti MM; McDaneld PM; Shelburne SA; Aitken SL
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509935
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems.
Tan SH; Ng TM; Chew KL; Yong J; Wu JE; Yap MY; Heng ST; Ng WHW; Wan S; Cheok SJH; Tambyah PA; Lye DC
Int J Antimicrob Agents; 2020 Feb; 55(2):105860. PubMed ID: 31841674
[TBL] [Abstract][Full Text] [Related]
17. [Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
Shinagawa N; Yura J; Mashita K; Matsuno S; Rikiyama T; Hirayama T; Tanaka T; Otsuka K; Iwai S; Nakagawa Y
Jpn J Antibiot; 1995 Mar; 48(3):346-67. PubMed ID: 7752449
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].
Oizumi K; Ohno T; Kawahara M; Kawaguchi S; Saisho M; Mitutake Y; Saito A; Tomizawa M; Koike T; Takebe K
Jpn J Antibiot; 1995 Apr; 48(4):449-81. PubMed ID: 7783313
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Cefmetazole for Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacterales vs Carbapenems: A Retrospective Study.
Kashihara E; Sada RM; Tsugihashi Y; Obayashi H; Nakamura A; Abe N; Miyake H; Akebo H
Open Forum Infect Dis; 2023 Oct; 10(10):ofad502. PubMed ID: 37901123
[TBL] [Abstract][Full Text] [Related]
20. [Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis].
Fukasawa C; Hoshino T; Kutsuna S; Sawada K; Sato H; Ishiwada N
Kansenshogaku Zasshi; 2013 Sep; 87(5):590-5. PubMed ID: 24195168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
